Gufic Biosciences Ltd.

₹284.75

- 2.90 (-1.01%)

04:01 pm - close price

BSE: GUFICBIO

NSE: GUFICBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 6.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 13.48Good: 20

🟡

Current Ratio

Bad: 1Current: 1.61Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 12.29Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 26.54Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 6.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 13.48Good: 20

🟡

Current Ratio

Bad: 1Current: 1.61Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 12.29Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 26.54Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	214.87	201.78	194.99	202.81
Expenditure+	175.51	165.32	160.77	167.03
Other Income+	0.33	0.42	0.88	1.26
Operating Profit	39.37	36.45	34.23	35.78
Interest	4.46	3.18	3.65	4.62
Depreciation and Amortization	4.30	4.14	4.34	4.30
Profit Before Tax	30.95	29.56	27.12	28.11
Tax+	7.74	7.30	7.07	7.25
Net Profit	23.21	22.26	20.05	20.86

Profit & Loss

In Rs. Cr.	202403	202503
Sales	80666.57	81980.60
Operational Expenses+	65936.51	68370.54
Operating Profit	14730.06	13610.06
Other Income	217.72	362.65
OPM %	18.26	16.60
Depreciation and Amortisation	1701.72	2106.46
Interest	1678.91	2451.90
Profit Before Tax	11567.15	9414.35
Tax	3156.54	2447.13
Net Profit	8613.56	6964.96

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	-	-	109254.14	116936.37
Liabilities+	0.00	0.00	0.00	109254.14	116936.37

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	-	-	-745.71	12256.79
Cash from Investing Activity	-	-	-	-10238.89	-7077.73
Cash from Financing Activity	-	-	-	8238.10	-3720.41
Net Cash Flow	-	-	-	-2746.50	1458.65
Opening Cash & Cash Equivalents	-	-	-	2860.19	113.68
Closing Cash & Cash Equivalents	-	-	-	113.69	1572.33

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	72.50	72.50	72.50	72.52	72.51	72.51	72.51	72.50	72.51	72.51
Public+	27.49	27.49	27.50	27.48	27.49	27.49	27.49	27.50	27.49	27.49
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	29223	30362	31420	31876	31844	33299	32825	32250	34695	34424

Corporate Actions

No corporate actions available for this company

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-	-	-	-745.71	12256.79
Cash from Investing Activity	-	-	-	-10238.89	-7077.73
Cash from Financing Activity	-	-	-	8238.10	-3720.41
Net Cash Flow	-	-	-	-2746.50	1458.65
Opening Cash & Cash Equivalents	-	-	-	2860.19	113.68
Closing Cash & Cash Equivalents	-	-	-	113.69	1572.33

Ratios

Reported EPS

Bad: 2Current: 6.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 13.48Good: 20

🟡

Current Ratio

Bad: 1Current: 1.61Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 12.29Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 26.54Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 6.95Good: 5

✅

Adjusted EPS

Bad: 3Current: 6.95Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 13.48Good: 20

🟡

Current Ratio

Bad: 1Current: 1.61Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 12.29Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 26.54Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Profit & Loss

In Rs. Cr.	202403	202503
Sales	80666.57	81980.60
Operational Expenses+	65936.51	68370.54
Operating Profit	14730.06	13610.06
Other Income	217.72	362.65
OPM %	18.26	16.60
Depreciation and Amortisation	1701.72	2106.46
Interest	1678.91	2451.90
Profit Before Tax	11567.15	9414.35
Tax	3156.54	2447.13
Net Profit	8613.56	6964.96

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	214.87	201.78	194.99	202.81
Expenditure+	175.51	165.32	160.77	167.03
Other Income+	0.33	0.42	0.88	1.26
Operating Profit	39.37	36.45	34.23	35.78
Interest	4.46	3.18	3.65	4.62
Depreciation and Amortization	4.30	4.14	4.34	4.30
Profit Before Tax	30.95	29.56	27.12	28.11
Tax+	7.74	7.30	7.07	7.25
Net Profit	23.21	22.26	20.05	20.86

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	-	-	-	109254.14	116936.37
Liabilities+	0.00	0.00	0.00	109254.14	116936.37

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Corporate Actions

No corporate actions available for this company

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	72.50	72.50	72.50	72.52	72.51	72.51	72.51	72.50	72.51	72.51
Public+	27.49	27.49	27.50	27.48	27.49	27.49	27.49	27.50	27.49	27.49
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	29223	30362	31420	31876	31844	33299	32825	32250	34695	34424

Gufic Biosciences Ltd.

₹284.75

- 2.90 (-1.01%)

04:01 pm - close price

BSE: GUFICBIO

NSE: GUFICBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview